Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;18(7):919-27.
doi: 10.1093/neuonc/now025. Epub 2016 Mar 15.

Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling

Affiliations

Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling

Dominique Figarella-Branger et al. Neuro Oncol. 2016 Jul.

Abstract

Background: Clear cell ependymoma is one of the 4 main histological subtypes of ependymomas defined by the World Health Organization (WHO) classification of tumors of the CNS. DNA methylation profiling can distinguish 4 subgroups of intracranial ependymomas, including supratentorial (ST) ependymomas with Yes-associated protein 1 fusion (YAP1), ST ependymomas with fusion of v-rel avian reticuloendotheliosis viral oncogene homolog A (RELA), posterior fossa ependymomas with balanced genome, and posterior fossa ependymomas with chromosomal instability. In addition, trisomy 19 is a genomic hallmark of ependymomas with rich branching capillaries. However, the relation of histological and molecular subtypes is unclear.

Methods: Here, we report a series of 20 ependymomas histologically defined by clear cells and branching capillaries.

Results: We observed a strong male predominance. Median age at surgery was 10.4 years (range, 0.8-68.4). All cases were ST, cortical, contrast enhancing, and most often frontal, cystic, and calcified. All tumors qualified as WHO grade III. Some of them exhibited neuronal differentiation. Trisomy 19 was recorded in 13 cases. All samples strongly accumulated p65RelA protein within nuclei, indicating pathological activation of the nuclear factor-kappaB pathway. We identified causative C11ORF95-RELA fusion in almost all cases. Median progression-free survival and overall survival were 11.4 years (95% CI: 5.1-17.8) and not reached, respectively.

Conclusion: ST clear cell ependymomas with branching capillaries display characteristic clinicopathological features and are associated with pathological activation of nuclear factor-kappaB signaling, which may indicate a potential novel target for therapy in these patients.

Keywords: NF kappa B; RelA; clear cell ependymomas; intracranial; trisomy 19.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
(A, B, hematoxylin/eosin staining) Clear cell ependymomas appeared as densely cellular lesions, composed of uniform closely packed cells, with discrete perivascular pseudorosettes and presenting a branched capillary network reminiscent of oligodendroglioma. Note microvascular proliferation and necrosis (arrow in A) and mitotic figure (arrow in B). (C) GFAP immunostaining shows a perivascular pattern. (D) Some tumors express neurofilament and exhibit bipolar morphology. (E) Interphase FISH analysis using 19p13.3 (green) and 19q13.2 (orange) dual-color probes showing numerous nuclei with 3 or 4 copies of 19q. (F) Nuclear p65RelA accumulation was detected in a clear cell ependymoma. Scale bars: 100 µm (A), 50 µm (B, C, F), 25 µm (D), and 10 µm (E).
Fig. 2.
Fig. 2.
Typical neuroradiological features of clear cell ependymoma: cortical and cystic lesion on (A) T1-weighted sequence with (B) a mural nodule strongly enhanced after gadolinium injection. Case #19.
Fig. 3.
Fig. 3.
(A) OS and (B) PFS for the clear cell ependymoma cohort. (C) OS and (D) PFS for patients with clear cell ependymoma stratified according to age (< or ≥ 18 y).

Comment in

References

    1. Ostrom QT, Gittleman H, Liao P et al. . CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol. 2014;16(Suppl 4):iv1–iv63. - PMC - PubMed
    1. Pajtler KW, Witt H, Sill M et al. . Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell. 2015;27(5):728–743. - PMC - PubMed
    1. Kilday JP, Rahman R, Dyer S et al. . Pediatric ependymoma: biological perspectives. Mol Cancer Res. 2009;7(6):765–786. - PubMed
    1. Metellus P, Barrie M, Figarella-Branger D et al. . Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients. Brain. 2007;130(Pt 5):1338–1349. - PubMed
    1. Figarella-Branger D, Civatte M, Bouvier-Labit C et al. . Prognostic factors in intracranial ependymomas in children. J Neurosurg. 2000;93(4):605–613. - PubMed

Publication types